These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3144920)

  • 1. Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand.
    Sirisanthana T; Nelson KE; Ezzell JW; Abshire TG
    Am J Trop Med Hyg; 1988 Dec; 39(6):575-81. PubMed ID: 3144920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay.
    Harrison LH; Ezzell JW; Abshire TG; Kidd S; Kaufmann AF
    J Infect Dis; 1989 Oct; 160(4):706-10. PubMed ID: 2507648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of clinical and serological findings for diagnosis of cutaneous anthrax infection after an outbreak.
    Gulseren D; Süzük-Yıldız S; Çelebi B; Kılıç S
    Cutan Ocul Toxicol; 2017 Sep; 36(3):289-293. PubMed ID: 28076993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes.
    Dumas EK; Demiraslan H; Ingram RJ; Sparks RM; Muns E; Zamora A; Larabee J; Garman L; Ballard JD; Boons GJ; James JA; Kayabas U; Doganay M; Farris AD
    PLoS One; 2020; 15(4):e0230782. PubMed ID: 32294093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ELISA using a recombinant chimera of protective antigen and lethal factor for serodiagnosis of cutaneous anthrax in India.
    Varshney A; Puranik N; Kumar M; Pal V; Padmaja J; Goel AK
    Biologicals; 2019 Jan; 57():55-60. PubMed ID: 30635155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
    Turnbull PC; Leppla SH; Broster MG; Quinn CP; Melling J
    Med Microbiol Immunol; 1988; 177(5):293-303. PubMed ID: 3139974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.
    Quinn CP; Semenova VA; Elie CM; Romero-Steiner S; Greene C; Li H; Stamey K; Steward-Clark E; Schmidt DS; Mothershed E; Pruckler J; Schwartz S; Benson RF; Helsel LO; Holder PF; Johnson SE; Kellum M; Messmer T; Thacker WL; Besser L; Plikaytis BD; Taylor TH; Freeman AE; Wallace KJ; Dull P; Sejvar J; Bruce E; Moreno R; Schuchat A; Lingappa JR; Martin SK; Walls J; Bronsdon M; Carlone GM; Bajani-Ari M; Ashford DA; Stephens DS; Perkins BA
    Emerg Infect Dis; 2002 Oct; 8(10):1103-10. PubMed ID: 12396924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
    Turnbull PC; Broster MG; Carman JA; Manchee RJ; Melling J
    Infect Immun; 1986 May; 52(2):356-63. PubMed ID: 3084381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serodiagnosis of human cutaneous anthrax in India using an indirect anti-lethal factor IgG enzyme-linked immunosorbent assay.
    Ghosh N; Tomar I; Lukka H; Goel AK
    Clin Vaccine Immunol; 2013 Feb; 20(2):282-6. PubMed ID: 23269414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
    Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
    Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of a Bacillus anthracis protective antigen domain-1 in-house ELISA for the detection of anti-protective antigen antibodies in cattle in Zambia.
    Simbotwe M; Fujikura D; Ohnuma M; Omori R; Furuta Y; Muuka GM; Hang'ombe BM; Higashi H
    PLoS One; 2018; 13(10):e0205986. PubMed ID: 30335853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
    Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera.
    Verma M; Suryanarayana N; Tuteja U; Thavachelvam K; Rao MK; Bhargava R; Shukla S
    Toxicon; 2017 Dec; 139():58-65. PubMed ID: 28919458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening of full human anthrax lethal factor neutralizing antibody in transgenic mice].
    Wang X; Chi X; Liu J; Liu W; Liu S; Qiu S; Wen Z; Fan P; Liu K; Song X; Fu L; Zhang J; Yu C
    Sheng Wu Gong Cheng Xue Bao; 2016 Nov; 32(11):1590-1599. PubMed ID: 29034628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood.
    Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Snawder JE; Robertson SA; Quinn CP
    Clin Vaccine Immunol; 2006 May; 13(5):541-6. PubMed ID: 16682473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.
    Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Semenova V; Steward-Clark E; Stamey K; Freeman AE; Quinn CP; Snawder JE
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):50-5. PubMed ID: 14715544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of monoclonal antibodies to protective antigen of Bacillus anthracis.
    Sastry KS; Tuteja U; Batra HV
    Indian J Exp Biol; 2003 Feb; 41(2):123-8. PubMed ID: 15255603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.